Search research articles
Contact Us
Filters
Showing results (111-120 of 287) with videos related to
Page
of 29
Sort By:
The Journal of Antimicrobial Chemotherapy
|
November 19, 2016
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
Kate El Bouzidi, Ellen White, Jean L Mbisa, et al.
The Lancet. Global Health
|
June 29, 2026
Sustaining progress in HIV care in Africa with a transition to enabled self-care: a modelling study
Andrew N Phillips, Kenly Sikwese, Valentina Cambiano, et al.
The Lancet. HIV
|
May 9, 2017
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
Jemma O'Connor, Colette Smith, Fiona C Lampe, et al.
The Journal of Infectious Diseases
|
October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression
Andrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
AIDS (London, England)
|
March 20, 2010
Long-term trends in adherence to antiretroviral therapy from start of HAART
Valentina Cambiano, Fiona C Lampe, Alison J Rodger, et al.
AIDS (London, England)
|
April 18, 2003
The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy
Colette J Smith, Caroline A Sabin, Fiona C Lampe, et al.
The Journal of Infectious Diseases
|
May 2, 2016
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection
Álvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
JMIR Research Protocols
|
June 17, 2016
Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study)
Janey Sewell, Andrew Speakman, Andrew N Phillips, et al.
AIDS (London, England)
|
November 7, 2015
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Inma Jarrin, Nikos Pantazis, Judith Dalmau, et al.
AIDS (London, England)
|
August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score
Amanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 287) with videos related to
Sort By:
Page
of 29
The Journal of Antimicrobial Chemotherapy
|
November 19, 2016
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
Kate El Bouzidi, Ellen White, Jean L Mbisa, et al.
The Lancet. Global Health
|
June 29, 2026
Sustaining progress in HIV care in Africa with a transition to enabled self-care: a modelling study
Andrew N Phillips, Kenly Sikwese, Valentina Cambiano, et al.
The Lancet. HIV
|
May 9, 2017
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
Jemma O'Connor, Colette Smith, Fiona C Lampe, et al.
The Journal of Infectious Diseases
|
October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression
Andrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
AIDS (London, England)
|
March 20, 2010
Long-term trends in adherence to antiretroviral therapy from start of HAART
Valentina Cambiano, Fiona C Lampe, Alison J Rodger, et al.
AIDS (London, England)
|
April 18, 2003
The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy
Colette J Smith, Caroline A Sabin, Fiona C Lampe, et al.
The Journal of Infectious Diseases
|
May 2, 2016
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection
Álvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
JMIR Research Protocols
|
June 17, 2016
Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study)
Janey Sewell, Andrew Speakman, Andrew N Phillips, et al.
AIDS (London, England)
|
November 7, 2015
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Inma Jarrin, Nikos Pantazis, Judith Dalmau, et al.
AIDS (London, England)
|
August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score
Amanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
Page
of 29